Product Center
The launch meeting of the Phase III clinical trial of the quadrivalent influenza virus subunit vaccine (aged 6-35 months) was successfully completed
- Categories:Company news
- Author:
- Origin:
- Time of issue:2023-02-04
- Views:
(Summary description)In the old year, a thousand pieces of brocade have been showcased, and in the new year, we will make another hundred feet of progress! On January 31st, the kickoff meeting for the Phase III clinical t
The launch meeting of the Phase III clinical trial of the quadrivalent influenza virus subunit vaccine (aged 6-35 months) was successfully completed
(Summary description)In the old year, a thousand pieces of brocade have been showcased, and in the new year, we will make another hundred feet of progress! On January 31st, the kickoff meeting for the Phase III clinical t
- Categories:Company news
- Author:
- Origin:
- Time of issue:2023-02-04 16:17
- Views:
Relevant information
-
Influenza virus subunit vaccine (adjuvant) IND application approvedRecently, Ab&B Bio-Tech Co.,Ltd（Ab&B Bio）and its subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) jointly applied for a Class I new drug "Influenza Virus Subunit Vaccine (Adjuvant)" IND application, which has been approved by the Drug Evaluation Center (CDE) of the China National Medical Products Administration. The approval of this vaccine marks the completion of the full coverage of the company's subunit influenza vaccine product pipeline for trivalent and quadrivalent influenza virus subunit vaccines, providing the most accurate selection for different age groups and different demand groups. - The application for the marketing of trivalent influenza virus subunit vaccine has been accepted! 10-08
- Breaking through bottleneck technology, significant progress has been made in the research and development of new adjuvants 08-26
- Obtained recognition as one of the first offshore innovation centers for enterprises in Taizhou 08-14
- Recombinant herpes zoster vaccine (CHO cells) IND application approved 08-13
Have a project？Get a touch!
Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio
Contact
E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
